May 05-06 Novel treatment strategies in precision cancer medicine in TJCC


The most influential annual event in cancer treatment in Taiwan, the 23rd Taiwan Joint Cancer Conference will be held at Taipei Marriot Hotel from 5th-6th May. ACT Genomics invites the Deputy Director of Tokyo Medical and Dental University Cancer Center, Dr. Sadakatsu Ikeda as guest speaker and the Director of National Taiwan Hospital Graduate Institute of Oncology, Dr. James Chih-Hsin Yang as moderator, to share insights on novel treatment strategies in precision cancer medicine on 5th May 15:30-16:30. Novel treatment strategies, such as immune therapy and combination therapy of molecular targeted agents, are emerging to overcome the limited duration of response in common monotherapy treatment strategy. ACT Genomics will introduce how cancer genomic profiling services can assist the novel cancer treatment strategies in A29 display area.